Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000501226 | SCV000595797 | pathogenic | Meckel syndrome, type 1 | 2016-05-19 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000823733 | SCV000964603 | pathogenic | Familial aplasia of the vermis; Meckel-Gruber syndrome | 2024-01-09 | criteria provided, single submitter | clinical testing | This sequence change results in a frameshift in the MKS1 gene (p.Glu471Glyfs*120). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 89 amino acid(s) of the MKS1 protein and extend the protein by 30 additional amino acid residues. This variant is present in population databases (rs762668200, gnomAD 0.09%). This variant has not been reported in the literature in individuals affected with MKS1-related conditions. ClinVar contains an entry for this variant (Variation ID: 435876). This variant results in an extension of the MKS1 protein. Other variant(s) that result in a similarly extended protein product (p.Thr485Argfs*107) have been determined to be pathogenic (PMID: 17185389, 17397051). This suggests that these extensions are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |
Medical Genetics Center, |
RCV000501226 | SCV003915600 | likely pathogenic | Meckel syndrome, type 1 | 2021-03-19 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003476196 | SCV004194921 | likely pathogenic | Bardet-Biedl syndrome 13 | 2023-10-17 | criteria provided, single submitter | clinical testing |